Review



anti cd133 pe cy7 antibody  (Miltenyi Biotec)


Bioz Verified Symbol Miltenyi Biotec is a verified supplier
Bioz Manufacturer Symbol Miltenyi Biotec manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    Miltenyi Biotec anti cd133 pe cy7 antibody
    Anti Cd133 Pe Cy7 Antibody, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 160 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti cd133 pe cy7 antibody/product/Miltenyi Biotec
    Average 93 stars, based on 160 article reviews
    anti cd133 pe cy7 antibody - by Bioz Stars, 2026-06
    93/100 stars

    Images



    Similar Products

    anti cd133 pe cy7 antibody  (Miltenyi Biotec)
    93
    Miltenyi Biotec anti cd133 pe cy7 antibody
    Anti Cd133 Pe Cy7 Antibody, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti cd133 pe cy7 antibody/product/Miltenyi Biotec
    Average 93 stars, based on 1 article reviews
    anti cd133 pe cy7 antibody - by Bioz Stars, 2026-06
    93/100 stars
    		  Buy from Supplier
    pe cy7 conjugated anti cd133  (Bioss)
    90
    Bioss pe cy7 conjugated anti cd133
    <t>CD133</t> and MVD in the border zone of MI. (A) Immunofluorescence on days 7 after MI. (B) Expression of CD133 stained by immunofluorescence (per/field). (C) MVD stained by CD31 (per/field). CD133 present star like and distribute on vessels marked by CD31, suggesting that angiogenesis might be promoted by EPCs marked by CD133. ∗∗ P < 0.01 compared with the sham group; # P < 0.05 and ## P < 0.01 compared with the model group; Δ P < 0.05 compared with the VA group. N = 8.
    Pe Cy7 Conjugated Anti Cd133, supplied by Bioss, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pe cy7 conjugated anti cd133/product/Bioss
    Average 90 stars, based on 1 article reviews
    pe cy7 conjugated anti cd133 - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier
    fitc-, pe-, allophycocyanin cy7 (apccy7)– conjugated anti- d34, cd133/1 cd45  (Becton Dickinson)
    90
    Becton Dickinson fitc-, pe-, allophycocyanin cy7 (apccy7)– conjugated anti- d34, cd133/1 cd45
    <t>CD133</t> and MVD in the border zone of MI. (A) Immunofluorescence on days 7 after MI. (B) Expression of CD133 stained by immunofluorescence (per/field). (C) MVD stained by CD31 (per/field). CD133 present star like and distribute on vessels marked by CD31, suggesting that angiogenesis might be promoted by EPCs marked by CD133. ∗∗ P < 0.01 compared with the sham group; # P < 0.05 and ## P < 0.01 compared with the model group; Δ P < 0.05 compared with the VA group. N = 8.
    Fitc , Pe , Allophycocyanin Cy7 (Apccy7)– Conjugated Anti D34, Cd133/1 Cd45, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fitc-, pe-, allophycocyanin cy7 (apccy7)– conjugated anti- d34, cd133/1 cd45/product/Becton Dickinson
    Average 90 stars, based on 1 article reviews
    fitc-, pe-, allophycocyanin cy7 (apccy7)– conjugated anti- d34, cd133/1 cd45 - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier
    pe-cy7 anti-human cd133 antibody  (Becton Dickinson)
    90
    Becton Dickinson pe-cy7 anti-human cd133 antibody
    Differentiation of SPC25+ from SPC25- PrC cells with genetic manipulation. ( A ) The DU145 and LNCap cell lines were transduced with 2 AAVs. The first AAV carries a luciferase and a mCherry fluorescent reporter under the control of a cytomegalovirus (CMV) promotor. The luciferase and mCherry reporters are connected by a p2A sequence to allow co-expression of 2 genes by one promoter with similar efficiency. Transduction of the cells with this AAV makes the cells red fluorescent to be sortable by flow cytometry and traceable in vivo by bioluminescence assay. The second AAV carries a nuclear green fluorescent protein (nGFP) reporter under the control of a SPC25 promoter. Transduction of the cells with this AAV makes the SPC25+ cells green fluorescent in the nuclei to be sortable by flow cytometry. Co-transduction of the cells with these 2 AAVs resulted in two populations of interest. Population 1, red fluorescent (expressing mCherry but not nGFP) cells represent SPC25- cells. Population 2, yellow fluorescent (expressing both mCherry and nGFP) cells represent SPC25+ cells. ( B ) The flow cytometry analysis on infected DU145 and LNCap cells. ( C ) The purified transduced cells were examined for fluorescence in culture. ( D ) RT-qPCR for SPC25 in different cell fractions. ( E ) Flow cytometry for <t>CD133</t> in SPC25+ and SPC25- fractions. *p<0.05. N=5. Scale bars were 20 µm.
    Pe Cy7 Anti Human Cd133 Antibody, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pe-cy7 anti-human cd133 antibody/product/Becton Dickinson
    Average 90 stars, based on 1 article reviews
    pe-cy7 anti-human cd133 antibody - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier
    pecy7 conjugated anti cd133  (Bioss)
    90
    Bioss pecy7 conjugated anti cd133
    Differentiation of SPC25+ from SPC25- PrC cells with genetic manipulation. ( A ) The DU145 and LNCap cell lines were transduced with 2 AAVs. The first AAV carries a luciferase and a mCherry fluorescent reporter under the control of a cytomegalovirus (CMV) promotor. The luciferase and mCherry reporters are connected by a p2A sequence to allow co-expression of 2 genes by one promoter with similar efficiency. Transduction of the cells with this AAV makes the cells red fluorescent to be sortable by flow cytometry and traceable in vivo by bioluminescence assay. The second AAV carries a nuclear green fluorescent protein (nGFP) reporter under the control of a SPC25 promoter. Transduction of the cells with this AAV makes the SPC25+ cells green fluorescent in the nuclei to be sortable by flow cytometry. Co-transduction of the cells with these 2 AAVs resulted in two populations of interest. Population 1, red fluorescent (expressing mCherry but not nGFP) cells represent SPC25- cells. Population 2, yellow fluorescent (expressing both mCherry and nGFP) cells represent SPC25+ cells. ( B ) The flow cytometry analysis on infected DU145 and LNCap cells. ( C ) The purified transduced cells were examined for fluorescence in culture. ( D ) RT-qPCR for SPC25 in different cell fractions. ( E ) Flow cytometry for <t>CD133</t> in SPC25+ and SPC25- fractions. *p<0.05. N=5. Scale bars were 20 µm.
    Pecy7 Conjugated Anti Cd133, supplied by Bioss, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pecy7 conjugated anti cd133/product/Bioss
    Average 90 stars, based on 1 article reviews
    pecy7 conjugated anti cd133 - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    CD133 and MVD in the border zone of MI. (A) Immunofluorescence on days 7 after MI. (B) Expression of CD133 stained by immunofluorescence (per/field). (C) MVD stained by CD31 (per/field). CD133 present star like and distribute on vessels marked by CD31, suggesting that angiogenesis might be promoted by EPCs marked by CD133. ∗∗ P < 0.01 compared with the sham group; # P < 0.05 and ## P < 0.01 compared with the model group; Δ P < 0.05 compared with the VA group. N = 8.

    Journal: Frontiers in Physiology

    Article Title: Velvet Antler Mobilizes Endothelial Progenitor Cells to Promote Angiogenesis and Repair Vascular Endothelial Injury in Rats Following Myocardial Infarction

    doi: 10.3389/fphys.2018.01940

    Figure Lengend Snippet: CD133 and MVD in the border zone of MI. (A) Immunofluorescence on days 7 after MI. (B) Expression of CD133 stained by immunofluorescence (per/field). (C) MVD stained by CD31 (per/field). CD133 present star like and distribute on vessels marked by CD31, suggesting that angiogenesis might be promoted by EPCs marked by CD133. ∗∗ P < 0.01 compared with the sham group; # P < 0.05 and ## P < 0.01 compared with the model group; Δ P < 0.05 compared with the VA group. N = 8.

    Article Snippet: PE-conjugated anti-CD34 (Bioss, China), PE-CY7 conjugated anti-CD133 (Bioss), and FITC conjugated anti- VEGFR2 antibody (Bioss) were used.

    Techniques: Immunofluorescence, Expressing, Staining

    Differentiation of SPC25+ from SPC25- PrC cells with genetic manipulation. ( A ) The DU145 and LNCap cell lines were transduced with 2 AAVs. The first AAV carries a luciferase and a mCherry fluorescent reporter under the control of a cytomegalovirus (CMV) promotor. The luciferase and mCherry reporters are connected by a p2A sequence to allow co-expression of 2 genes by one promoter with similar efficiency. Transduction of the cells with this AAV makes the cells red fluorescent to be sortable by flow cytometry and traceable in vivo by bioluminescence assay. The second AAV carries a nuclear green fluorescent protein (nGFP) reporter under the control of a SPC25 promoter. Transduction of the cells with this AAV makes the SPC25+ cells green fluorescent in the nuclei to be sortable by flow cytometry. Co-transduction of the cells with these 2 AAVs resulted in two populations of interest. Population 1, red fluorescent (expressing mCherry but not nGFP) cells represent SPC25- cells. Population 2, yellow fluorescent (expressing both mCherry and nGFP) cells represent SPC25+ cells. ( B ) The flow cytometry analysis on infected DU145 and LNCap cells. ( C ) The purified transduced cells were examined for fluorescence in culture. ( D ) RT-qPCR for SPC25 in different cell fractions. ( E ) Flow cytometry for CD133 in SPC25+ and SPC25- fractions. *p<0.05. N=5. Scale bars were 20 µm.

    Journal: Aging (Albany NY)

    Article Title: Spindle pole body component 25 regulates stemness of prostate cancer cells

    doi: 10.18632/aging.101631

    Figure Lengend Snippet: Differentiation of SPC25+ from SPC25- PrC cells with genetic manipulation. ( A ) The DU145 and LNCap cell lines were transduced with 2 AAVs. The first AAV carries a luciferase and a mCherry fluorescent reporter under the control of a cytomegalovirus (CMV) promotor. The luciferase and mCherry reporters are connected by a p2A sequence to allow co-expression of 2 genes by one promoter with similar efficiency. Transduction of the cells with this AAV makes the cells red fluorescent to be sortable by flow cytometry and traceable in vivo by bioluminescence assay. The second AAV carries a nuclear green fluorescent protein (nGFP) reporter under the control of a SPC25 promoter. Transduction of the cells with this AAV makes the SPC25+ cells green fluorescent in the nuclei to be sortable by flow cytometry. Co-transduction of the cells with these 2 AAVs resulted in two populations of interest. Population 1, red fluorescent (expressing mCherry but not nGFP) cells represent SPC25- cells. Population 2, yellow fluorescent (expressing both mCherry and nGFP) cells represent SPC25+ cells. ( B ) The flow cytometry analysis on infected DU145 and LNCap cells. ( C ) The purified transduced cells were examined for fluorescence in culture. ( D ) RT-qPCR for SPC25 in different cell fractions. ( E ) Flow cytometry for CD133 in SPC25+ and SPC25- fractions. *p<0.05. N=5. Scale bars were 20 µm.

    Article Snippet: For CD133, a PE-cy7 anti-human CD133 antibody (Becton-Dickinson Biosciences, San Jose, CA, USA) was used.

    Techniques: Transduction, Luciferase, Control, Sequencing, Expressing, Flow Cytometry, In Vivo, ATP Bioluminescent Assay, Infection, Purification, Fluorescence, Quantitative RT-PCR